NeutriSci Announces Advanced Talks With Several of Canada's Leading Medical Marijuana Companies

NeutriSci (TSXV:NU) has announced it is in advanced discussions about product formulation with several Canadian cannabis companies.
As quoted in the press release:

NeutriSci has been working directly with several companies in Canada’s cannabis sector with a view to using NeutriSci’s proprietary formulation and form factor within the industry. This formulation utilizes NeutriSci’s melt technology and the pterostilbene molecule in combination with various cannabis and cannabidiol actives. Based on research to-date, the Company believes its formulation will enable manufacturers of edible cannabis products to use less active ingredients and better define dose control properties, while still achieving the same desired effects. These effects are like the mechanism that is achieved within neuenergy®, which increases the overall efficacy of standard caffeine by more than 5x.
NeutriSci President Mr. Glen Rehman stated, “We are excited about the potential synergies and partnerships these talks may produce. We have been working with these parties for several months now and are very encouraged with the progress to date.”

Click here to read the full press release.

Source: www.neutrisci.com